Who Owns GPCR?

Structure Therapeutics Inc. — Institutional Ownership & 13F Holdings

$41.25

-2.33 (-5.35%)

Market Cap

$3.3B

Shares Outstanding

57,566,667

Institutional Holders

151

Total Inst. Value

$989.9M

% of Float Held

QoQ Holder Change

+47

Institutional data as of Q1 2025

New Positions

25

Closed Positions

34

Increased

50

Decreased

47

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1DEERFIELD MANAGEMENT COMPANY, L.P.$181.0M10,455,396
2WELLINGTON MANAGEMENT GROUP LLP$134.9M7,791,183
3FMR LLC$101.8M5,883,707
4Deep Track Capital, LP$71.0M4,100,000
5Capital Research Global Investors$37.5M2,164,145
6Vestal Point Capital, LP$31.0M1,788,990
7BVF INC/IL$30.7M1,771,417
8Capital International Investors$28.0M1,619,026
9AMERIPRISE FINANCIAL INC$25.7M1,481,809
10DRIEHAUS CAPITAL MANAGEMENT LLC$22.0M1,272,743

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold GPCR?

As of Q1 2025, 151 institutional investors report holding GPCR (Structure Therapeutics Inc.) in their 13F filings.

Which hedge fund owns the most GPCR?

The largest institutional holder of GPCR is DEERFIELD MANAGEMENT COMPANY, L.P. with $181.0M in shares.

Are institutions buying or selling GPCR?

This quarter, 25 institutions opened new positions in GPCR and 34 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.